Zhejiang Taimei Medical Technology (2576) Stock Overview
Zhejiang Taimei Medical Technology Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 2576 from our risk checks.
2576 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Zhejiang Taimei Medical Technology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$4.20 |
| 52 Week High | HK$5.88 |
| 52 Week Low | HK$3.02 |
| Beta | 0 |
| 1 Month Change | -0.71% |
| 3 Month Change | -8.10% |
| 1 Year Change | -20.30% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -54.35% |
Recent News & Updates
We're Hopeful That Zhejiang Taimei Medical Technology (HKG:2576) Will Use Its Cash Wisely
Sep 30
There's No Escaping Zhejiang Taimei Medical Technology Co., Ltd.'s (HKG:2576) Muted Revenues Despite A 26% Share Price Rise
Jul 22Zhejiang Taimei Medical Technology Co., Ltd.'s (HKG:2576) 32% Dip In Price Shows Sentiment Is Matching Revenues
Apr 07Recent updates
We're Hopeful That Zhejiang Taimei Medical Technology (HKG:2576) Will Use Its Cash Wisely
Sep 30There's No Escaping Zhejiang Taimei Medical Technology Co., Ltd.'s (HKG:2576) Muted Revenues Despite A 26% Share Price Rise
Jul 22Zhejiang Taimei Medical Technology Co., Ltd.'s (HKG:2576) 32% Dip In Price Shows Sentiment Is Matching Revenues
Apr 07Shareholder Returns
| 2576 | HK Life Sciences | HK Market | |
|---|---|---|---|
| 7D | -6.3% | -0.9% | 2.7% |
| 1Y | -20.3% | 117.5% | 41.9% |
Return vs Industry: 2576 underperformed the Hong Kong Life Sciences industry which returned 117.5% over the past year.
Return vs Market: 2576 underperformed the Hong Kong Market which returned 41.9% over the past year.
Price Volatility
| 2576 volatility | |
|---|---|
| 2576 Average Weekly Movement | 6.8% |
| Life Sciences Industry Average Movement | 7.5% |
| Market Average Movement | 7.0% |
| 10% most volatile stocks in HK Market | 14.7% |
| 10% least volatile stocks in HK Market | 3.3% |
Stable Share Price: 2576 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 2576's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | 656 | Yunyun Wan | www.taimei.com |
Zhejiang Taimei Medical Technology Co., Ltd. provides digital operation platform for the biopharma industry in China. The company offers TrialOS, a drug digital cooperation platform that connects the cycle of hospitals, pharmaceutical companies, third-party providers, regulatory authorities, patients, and other industry stakeholders; PharmaOS, a pharmaceutical digital marketing platform; and Enterprise-Medical Academic Interaction Platform, an enterprise-medical communication.
Zhejiang Taimei Medical Technology Co., Ltd. Fundamentals Summary
| 2576 fundamental statistics | |
|---|---|
| Market cap | HK$2.37b |
| Earnings (TTM) | -HK$72.58m |
| Revenue (TTM) | HK$572.24m |
Is 2576 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2576 income statement (TTM) | |
|---|---|
| Revenue | CN¥522.59m |
| Cost of Revenue | CN¥308.41m |
| Gross Profit | CN¥214.19m |
| Other Expenses | CN¥280.47m |
| Earnings | -CN¥66.28m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.12 |
| Gross Margin | 40.99% |
| Net Profit Margin | -12.68% |
| Debt/Equity Ratio | 0% |
How did 2576 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/14 00:14 |
| End of Day Share Price | 2025/11/14 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Zhejiang Taimei Medical Technology Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yang Liu | Morgan Stanley |